Gunma

The trials here

What the 10 trials at this site are about, from their registry records.

Conditions

• Childhood cancers4 trials
• Asthma2 trials
• Chronic kidney disease1 trial
• Chronic lymphocytic leukaemia1 trial
• Coronary artery disease1 trial
• Heart failure1 trial
• Lung cancer1 trial
• Lupus (SLE)1 trial
• Pancreatic cancer1 trial

Status

• Completed8 trials
• Active, not recruiting2 trials

Lead sponsor

• AstraZeneca10 trials

Running trials

• Active, not recruiting

  TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)

  NCT05729711· AstraZeneca· Source

• Active, not recruiting

  SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS)

  NCT05141201· AstraZeneca· Source

Closed trials

• Completed

  Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI

  NCT05826366· AstraZeneca· Source

• Completed

  LYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS)

  NCT05677308· AstraZeneca· Source

• Completed

  Forxiga CKD Japan Post-Marketing Surveillance (PMS)

  NCT05306210· AstraZeneca· Source

• Completed

  Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation

  NCT04872621· AstraZeneca· Source

• Completed

  LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS)

  NCT04889404· AstraZeneca· Source

• Completed

  Forxiga HF General Drug Use-Results Study

  NCT04865406· AstraZeneca· Source

• Completed

  FASENRA SCEI for Long-term Use

  NCT03588546· AstraZeneca· Source

• Completed

  Brilinta Clinical Experience Investigation

  NCT03212287· AstraZeneca· Source